Evidence map›Paper›PMID 30818760›Full record

ReviewInternational journal of molecular sciences2019

Cell Metabolism Control Through O-GlcNAcylation of STAT5: A Full or Empty Fuel Tank Makes a Big Difference for Cancer Cell Growth and Survival.

Manuel Rauth, Patricia Freund, Anna Orlova, Stefan Grünert, Nikola Tasic, Xiaonan Han, Hai-Bin Ruan, Heidi A Neubauer, Richard Moriggl

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. JAK-STAT Signaling in Autoimmunity and Cancer.ImmunoTargets and therapy · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Manuel RauthInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria. Manuel.Rauth@vetmeduni.ac.at.
Patricia FreundInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria. Patricia.Freund@vetmeduni.ac.at.
Anna OrlovaInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria. Anna.Orlova@lbicr.lbg.ac.at.
Stefan GrünertBiolution GmbH, 1030 Vienna, Austria. stefan.gruenert@biolution.net.ORCID 0000-0003-0241-9297
Nikola TasicBiolution GmbH, 1030 Vienna, Austria. tasic@biolution.net.
Xiaonan HanKey Laboratory of Human Disease Comparative Medicine, the Ministry of Health, Institute of Laboratory Animal Sciences (ILAS), Beijing 100730, China. Xiaonan.Han@cchmc.org.
Hai-Bin RuanDepartment of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA. hruan@umn.edu.
Heidi A NeubauerInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria. Heidi.Neubauer@vetmeduni.ac.at.ORCID 0000-0001-7372-7786
Richard MorigglInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, 1210 Vienna, Austria. richard.moriggl@vetmeduni.ac.at.ORCID 0000-0003-0918-9463
University of Veterinary Medicine Vienna · ATBiolution (Austria) · ATCincinnati Children's Hospital Medical Center · USUniversity of Minnesota Medical Center · US

Funding

Austrian Science Fund SFB-F06105Austrian Science Fund SFB F4707Österreichische Forschungsförderungsgesellschaft 854452
6 · The paper itself

Abstract

O-GlcNAcylation is a post-translational modification that influences tyrosine phosphorylation in healthy and malignant cells. O-GlcNAc is a product of the hexosamine biosynthetic pathway, a side pathway of glucose metabolism. It is essential for cell survival and proper gene regulation, mirroring the metabolic status of a cell. STAT3 and STAT5 proteins are essential transcription factors that can act in a mutational context-dependent manner as oncogenes or tumor suppressors. They regulate gene expression for vital processes such as cell differentiation, survival, or growth, and are also critically involved in metabolic control. The role of STAT3/5 proteins in metabolic processes is partly independent of their transcriptional regulatory role, but is still poorly understood. Interestingly, STAT3 and STAT5 are modified by O-GlcNAc in response to the metabolic status of the cell. Here, we discuss and summarize evidence of O-GlcNAcylation-regulating STAT function, focusing in particular on hyperactive STAT5A transplant studies in the hematopoietic system. We emphasize that a single O-GlcNAc modification is essential to promote development of neoplastic cell growth through enhancing STAT5A tyrosine phosphorylation. Inhibition of O-GlcNAcylation of STAT5A on threonine 92 lowers tyrosine phosphorylation of oncogenic STAT5A and ablates malignant transformation. We conclude on strategies for new therapeutic options to block O-GlcNAcylation in combination with tyrosine kinase inhibitors to target neoplastic cancer cell growth and survival.

Indexed as

Energy MetabolismAnimalsCell ProliferationCell SurvivalGlycosylationHumansNeoplasmsSignal TransductionSTAT5 Transcription FactorSTAT5 Transcription FactorJAK kinasesO-GlcNAcaseO-GlcNAc transferaseO-GlcNAcylationSTAT3STAT5ASTAT5Btyrosine phosphorylation

Identifiers

PMID30818760
PMCPMC6429193
OpenAlexW2917331076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.